| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |